With the blister packaging machine Noack N 921 and the micro dosing machine Macofar Micro...
Romaco is combining its two Italian production sites in Rastignano, Bologna. For this purpose the Italian Romaco
brands Macofar, Promatic and Unipac were physically consolidated. From now on, Romaco, the Italian subsidiary of the Romaco Group, will be located under one roof and centrally administered.
During the lead-up period, the packaging specialist’s location in Rastignano had already been comprehensively renovated and expanded. In total, approximately 110 employees have 6,500m² at their disposal.
The restructuring of the production site did not result in any staff cuts. In fact, the goal of the consolidation is to process the increasing volume of orders within the shortest possible time. With extensive investment and consistent implementation of ‘lean principles’, Romaco is optimising its working processes and expanding its production capacity.
The primary and secondary packaging of pharmaceutical products and cosmetics are the core activities of the Italian brands of the Romaco Group.
Macofar produces machines and full lines for filling liquids and powders, as well as capsules. Promatic has many years of know-how in the development of cartoning machines and case packers. And finally, Unipac has specialised in
the filling of semi-solids into tubes.
“The consolidation and reorganisation of Romaco increases our efficiency and effectiveness as well as our flexibility,” explains Paolo Naldi, managing director of Romaco at Rastignano. “The extensive investment in the
common location will contribute significantly to improvement of our quality and supply capacity.”
You are very welcome to visit Romaco at Pharmintech, 12 to 14 May 2010 in Bologna, Italy, in pavilion 22, at booth A3.
For the first time, the product feed on the Romaco Siebler HM 1E/240 horizontal strip...
As part of a modernization project, Colomer Italy decided to position its Romaco Unipac U...
Three Romaco Noack blister lines are currently in action at C.P.M ContractPharma. The compatibility of...